These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 6875117

  • 1. Clinical and electrophysiologic effects of chronic lorcainide therapy in refractory ventricular tachycardia.
    Saksena S, Rothbart ST, Cappello G, Bernstein A, Somani P.
    J Am Coll Cardiol; 1983 Sep; 2(3):538-44. PubMed ID: 6875117
    [No Abstract] [Full Text] [Related]

  • 2. Lorcainide for the treatment of refractory ventricular tachycardia: clinical and electrophysiologic results.
    Hanyok JJ, Kluger J, Chow MS, Fieldman A.
    J Clin Pharmacol; 1987 Apr; 27(4):278-82. PubMed ID: 3680584
    [Abstract] [Full Text] [Related]

  • 3. Long term lorcainide therapy guided by electrophysiology studies.
    Somberg J, Butler B, Flowers D, Tepper D, Torres V.
    Acta Cardiol; 1985 Apr; 40(6):621-36. PubMed ID: 3879419
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of lorcainide in patients with symptomatic ventricular tachycardia.
    Somberg JC, Butler B, Flowers D, Keefe D, Torres V, Miura D.
    Am J Cardiol; 1984 Aug 13; 54(4):43B-48B. PubMed ID: 6465046
    [Abstract] [Full Text] [Related]

  • 5. Comparison of noninvasive arrhythmia induction techniques with electrophysiologic studies and evaluation of lorcainide in patients with symptomatic ventricular tachycardia.
    Somberg JC, Butler B, Flowers D, Tepper D, Maguire W, Willens H, Keren G, Miura D.
    Am J Cardiol; 1984 Aug 13; 54(4):49B-54B. PubMed ID: 6465047
    [Abstract] [Full Text] [Related]

  • 6. Long-term lorcainide therapy in patients with ventricular tachycardia.
    Somberg J, Butler B, Flowers D, Keefe D, Torres V, Miura D.
    Am Heart J; 1985 Jan 13; 109(1):33-40. PubMed ID: 3966330
    [Abstract] [Full Text] [Related]

  • 7. Lorcainide in patients with refractory ventricular tachyarrhythmia.
    Chesnie B, Lampert S, Podrid P, Lown B.
    J Am Coll Cardiol; 1984 Jun 13; 3(6):1531-9. PubMed ID: 6715710
    [Abstract] [Full Text] [Related]

  • 8. Treatment with oral lorcainide in patients with sustained ventricular tachycardia and fibrillation.
    Echt DS, Shapiro M, Trusso J, Mason JW, Winkle RA.
    Am Heart J; 1985 Jan 13; 109(1):28-33. PubMed ID: 3966329
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the electrophysiologic effects of intravenous and oral lorcainide in patients with recurrent ventricular tachycardia.
    Echt DS, Mitchell LB, Kates RE, Winkle RA.
    Circulation; 1983 Aug 13; 68(2):392-9. PubMed ID: 6861314
    [Abstract] [Full Text] [Related]

  • 10. Electrophysiologic effects of lorcainide on the accessory pathway in the Wolff-Parkinson-White syndrome.
    Kasper W, Treese N, Meinertz T, Jähnchen E, Pop T.
    Am J Cardiol; 1983 Jun 13; 51(10):1618-22. PubMed ID: 6858867
    [Abstract] [Full Text] [Related]

  • 11. Lorcainide therapy for the high-risk patient post myocardial infarction.
    Somberg JC, Butler B, Torres V, Flowers D, Tepper D, Keefe D, Miura DS.
    Am J Cardiol; 1984 Aug 13; 54(4):37B-42B. PubMed ID: 6465045
    [Abstract] [Full Text] [Related]

  • 12. [The effects of lorcainide on the ECG pattern and left ventricular function in a patient with recurrent ventricular tachycardia].
    Sniezek-Maciejewska M, Bryniarski L, Mazurek S, Dubiel JP.
    Kardiol Pol; 1990 Aug 13; 33(9-10):28-31. PubMed ID: 2074642
    [Abstract] [Full Text] [Related]

  • 13. Antiarrhythmic effect of lorcainide during chronic treatment.
    Meinertz T, Kasper W, Kersting F, Bechtold H, Just H, Jähnchen E.
    Arzneimittelforschung; 1980 Aug 13; 30(9):1593-5. PubMed ID: 7193031
    [Abstract] [Full Text] [Related]

  • 14. Randomized double-blind placebo controlled crossover trial documenting oral lorcainide efficacy in suppression of symptomatic ventricular tachyarrhythmias.
    Keefe DL, Peters F, Winkle RA.
    Am Heart J; 1982 Apr 13; 103(4 Pt 1):511-8. PubMed ID: 7039282
    [Abstract] [Full Text] [Related]

  • 15. Electrophysiological effects of lorcainide, a new antiarrhythmic drug. Observations in patients with and without pre-excitation.
    Bär FW, Farré J, Ross D, Vanagt EJ, Gorgels AP, Wellens HJ.
    Br Heart J; 1981 Mar 13; 45(3):292-8. PubMed ID: 7470342
    [Abstract] [Full Text] [Related]

  • 16. Therapy for late post infarction ventricular tachycardia.
    Somberg JC, Butler B, Torres V, Tepper D, Keren G, Siegel L, Jentzer J, Miura DS.
    Angiology; 1985 Mar 13; 36(3):181-90. PubMed ID: 3896040
    [Abstract] [Full Text] [Related]

  • 17. [Clinical-electrophysiological study of the effect of lorcainide on induction of ventricular tachycardia (author's transl)].
    Breithardt G, Seipel L, Abendroth RR.
    Z Kardiol; 1981 Jul 13; 70(7):530-5. PubMed ID: 7269732
    [Abstract] [Full Text] [Related]

  • 18. Pharmacodynamics of the initiation of antiarrhythmic therapy with lorcainide.
    Winkle RA, Keefe DL, Rodriguez I, Kates RE.
    Am J Cardiol; 1984 Feb 01; 53(4):544-51. PubMed ID: 6198895
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of lorcainide, a new anti-arrhythmic agent.
    Lloyd EA, Workman LJ, Commerford PJ, Mabin TA.
    S Afr Med J; 1981 Dec 12; 60(24):929-31. PubMed ID: 7302777
    [Abstract] [Full Text] [Related]

  • 20. Acute effects of antiarrhythmic drugs on stable ventricular premature beats. Controlled comparison of lorcainide and lidocaine.
    Schmidt G, Klein G, Wirtzfeld A.
    Eur J Clin Pharmacol; 1985 Dec 12; 27(6):633-6. PubMed ID: 2580712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.